“STUDY ON SAFETY AND EFFECTIVENESS OF ORAL TOFACITINIB IN PATIENTS WITH REFRACTORY MODERATE TO SEVERE ATOPIC DERMATITIS” (2018) International Research Journal of Pharmacy, 9(8), pp. 125–128. doi:10.56802/gzfvmr94.